mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.9 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.0065 |
0.9 |